Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,894,129
+$527,384 QoQ
Shares Held
15,475
-0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.49%
of 13F equity value
Holder Rank
#1,470
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Round Hill Asset Management holds $42,939,237 across 7 Drug Manufacturers - General names. ABBV ranks #6 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
37,380 | $13,536,045 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,350 | $9,168,475 | |
| 3 | NVO |
Novo Nordisk A S
|
122,031 | $5,850,166 | |
| 4 | PFE |
Pfizer Inc
|
242,134 | $5,830,586 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,646 | $4,128,242 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
15,475 | $3,894,129 | |
| 7 | NVS |
Novartis AG
|
3,392 | $531,594 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,894,129 | 15,475 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,366,745 | 15,480 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,537,025 | 15,480 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,620,822 | 15,638 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,902,725 | 15,638 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,299,940 | 15,750 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,826,318 | 15,905 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,140,919 | 15,905 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,729,397 | 15,913 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,897,757 | 15,913 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,454,569 | 15,839 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,412,536 | 16,185 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,184,646 | 16,215 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,584,184 | 16,215 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,620,506 | 16,215 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,176,215 | 16,215 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,483,489 | 16,215 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,628,613 | 16,215 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,195,511 | 16,215 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,750,945 | 16,232 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,838,059 | 16,318 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,765,933 | 16,318 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,748,473 | 16,318 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,429,293 | 16,318 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,602,297 | 16,320 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||